Jinhe Biotechnology CO., LTD. (002688.SZ)
CNY 4.85
(4.08%)
CNY 4.85
(4.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 198.76 Million | 124.47 Million | 152.97 Million | 258.07 Million | 282.18 Million | 117.17 Million |
| Net Income | 94.43 Million | 118.04 Million | 122.08 Million | 139.19 Million | 190.32 Million | 164.4 Million |
| Depreciation & Amortization | 179.29 Million | 155.89 Million | 132.07 Million | 119.95 Million | 99.44 Million | 86.33 Million |
| Deferred income taxes | 6.69 Million | 2.74 Million | 2.4 Million | -9.82 Million | -9.53 Million | 2.12 Million |
| Stock-based compensation | 7.52 Million | - | - | - | - | - |
| Change in working capital | -166.2 Million | -217.88 Million | -182.68 Million | -89.92 Million | -101.85 Million | -205.71 Million |
| Other non-cash items | 56.41 Million | 68.42 Million | 81.49 Million | 88.85 Million | 94.27 Million | 72.16 Million |
| Investing Cash Flow | -534.18 Million | -386.79 Million | -397.98 Million | -204.4 Million | -184.08 Million | -192.02 Million |
| Investments in PPE | -457.21 Million | -402.15 Million | -383.72 Million | -204 Million | -178.84 Million | -170.17 Million |
| Acquisitions | -60.87 Million | 17.44 Million | -19.24 Million | 1200.00 | -6.9 Million | -20.41 Million |
| Investment purchases | -9 Million | -4.2 Million | -100 Thousand | -100 Thousand | - | -1.42 Million |
| Sales/Maturities of investments | 3.75 Million | 1.48 | 5.37 Million | -1200.00 | - | - |
| Other Investing Activities | -10.85 Million | 2.11 Million | -300 Thousand | -300.18 Thousand | 1.66 Million | -20.41 Million |
| Financing Cash Flow | 413.05 Million | 150.43 Million | 448.7 Million | 27.6 Million | -185.94 Million | 153.56 Million |
| Debt repayment | -600.25 Million | -995.52 Million | -1.57 Billion | -1.1 Billion | -900.93 Million | -677.69 Million |
| Dividends payments | -75.37 Million | -40.54 Million | -63.52 Million | -158.82 Million | -158.82 Million | -65.14 Million |
| Common Stock Repurchased | - | -131.89 Million | - | - | - | - |
| Common Stock Issuance | - | 131.89 Million | - | - | - | -1.45 Million |
| Other Financing Activities | -38.51 Million | 1.18 Billion | 2.12 Billion | 1.35 Billion | 937.77 Million | 896.4 Million |
| Accounts receivables | -183.89 Million | -152.49 Million | -138.63 Million | -8.21 Million | 8.6 Million | -58.48 Million |
| Accounts payables | -521.06 Thousand | 37.42 Million | 89.13 Million | -52.03 Million | -37.95 Million | -120.45 Million |
| Inventory | 11.51 Million | -105.56 Million | -135.58 Million | -19.84 Million | -62.97 Million | -28.9 Million |
| Other working capital | 3.84 Million | 2.74 Million | 2.4 Million | -9.82 Million | -9.53 Million | -176.8 Million |
| Cash at beginning of period | 410.92 Million | 501.2 Million | 299.66 Million | 225.54 Million | 311.84 Million | 231.72 Million |
| Cash at end of period | 497.62 Million | 410.92 Million | 501.2 Million | 299.66 Million | 225.54 Million | 311.84 Million |
| Capital Expenditure | -457.21 Million | -402.15 Million | -383.72 Million | -204 Million | -178.84 Million | -170.17 Million |
| Effect of forex changes on cash | 9.07 Million | 21.61 Million | -2.15 Million | -7.14 Million | 1.53 Million | 1.4 Million |
| Net cash flow / Change in cash | 86.7 Million | -90.28 Million | 201.53 Million | 74.12 Million | -86.3 Million | 80.12 Million |
| Free Cash Flow | -258.45 Million | -277.68 Million | -230.74 Million | 54.07 Million | 103.33 Million | -53 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 22.74 Million | 45.87 Million | 45.14 Million | 94.43 Million | -16.6 Million | 13.7 Million |
| Depreciation & Amortization | - | 47.59 Million | 47.59 Million | 179.29 Million | 43.49 Million | -93.23 Million |
| Deferred income taxes | - | - | - | 6.69 Million | - | - |
| Stock-based compensation | - | 7.06 Million | - | 7.52 Million | 7.52 Million | - |
| Change in working capital | - | -69.11 Million | - | -166.2 Million | -168.53 Million | 130.29 Million |
| Other non-cash items | 187.34 Million | 97.82 Million | 28.24 Million | 56.41 Million | 90.78 Million | 30.07 Million |
| Investing Cash Flow | -78.82 Million | -90.01 Million | -83.27 Million | -534.18 Million | -70.62 Million | -290.45 Million |
| Investments in PPE | -82.12 Million | -75.84 Million | -83.91 Million | -457.21 Million | -77.79 Million | -236.99 Million |
| Acquisitions | 1.08 Million | -787.94 Thousand | 676.65 Thousand | -60.87 Million | -60.87 Million | -18.27 Million |
| Investment purchases | 9 Million | -12.5 Million | - | -9 Million | 93.42 Million | -53.46 Million |
| Sales/Maturities of investments | - | 8 Million | - | 3.75 Million | 3 Million | 71.73 Million |
| Other Investing Activities | 3.29 Million | -1.65 Million | -130.4 Thousand | -10.85 Million | -29.13 Million | -53.46 Million |
| Financing Cash Flow | 31.9 Million | -44.85 Million | 110.61 Million | 413.05 Million | -22.45 Million | 254.23 Million |
| Debt repayment | -100.31 Million | -104.52 Million | -117.68 Million | -600.25 Million | -25.3 Million | -384.94 Million |
| Dividends payments | -23.29 Million | -97.85 Million | -17.82 Million | -75.37 Million | -75.37 Million | -17.66 Million |
| Common Stock Repurchased | 50.09 Million | -50.09 Million | - | - | - | -53.21 Million |
| Common Stock Issuance | - | - | - | - | - | -53.21 Million |
| Other Financing Activities | 155.51 Million | -51.52 Million | 10.75 Million | -38.51 Million | 24.83 Million | 763.26 Million |
| Accounts receivables | - | -24.77 Million | - | -183.89 Million | -183.89 Million | 40.9 Million |
| Accounts payables | - | - | - | -521.06 Thousand | - | - |
| Inventory | - | -48.58 Million | - | 11.51 Million | 11.51 Million | 89.38 Million |
| Other working capital | - | 4.24 Million | - | 3.84 Million | 3.84 Million | - |
| Cash at beginning of period | 562.63 Million | 599.72 Million | 497.62 Million | 410.92 Million | 555.87 Million | 512.04 Million |
| Cash at end of period | 725.02 Million | 562.63 Million | 599.72 Million | 497.62 Million | 497.62 Million | 555.87 Million |
| Capital Expenditure | -82.12 Million | -75.84 Million | -83.91 Million | -457.21 Million | -77.79 Million | -236.99 Million |
| Effect of forex changes on cash | -291.03 Thousand | 1.17 Million | 1.36 Million | 9.07 Million | 6.35 Million | -785.65 Thousand |
| Net cash flow / Change in cash | 162.38 Million | -37.08 Million | 102.09 Million | 86.7 Million | -58.24 Million | 43.82 Million |
| Free Cash Flow | 127.96 Million | 20.25 Million | -10.52 Million | -258.45 Million | -47.11 Million | -156.15 Million |
KUMPFIN
JZCP
IMTL
300421
MLNOV
KREBSBIO